NRX Pharmaceuticals, Inc. (NRXP): auditor change — NRx Pharmaceuticals replaces auditor Salberg & Company with Weinberg & Company

NRX Pharmaceuticals, Inc.

Engaged Weinberg & Company as independent auditor for FY ending Dec 31, 2025, effective Nov 20, 2025.
Dismissed Salberg & Company on Nov 24, 2025; no disagreements or reportable events in prior years.
Salberg's prior audit opinions contained a going-concern explanatory paragraph but were otherwise unqualified.
Weinberg had previously audited Dura Medical LLC, a subsidiary acquired by Hope Therapeutics.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

NRX Pharmaceuticals, Inc. engaged Weinberg & Company P.A. as its auditor.

Action: engagement
Auditor: Weinberg & Company P.A.

Exact text from the filing

Engagement of New Independent Registered Public Accounting Firm and Dismissal of Independent Registered Public Accounting Firm On November 20, 2025, the audit committee of the board of directors (the “Audit Committee”) of NRx Pharmaceuticals, Inc. (the “Corporation”) approved the engagement of Weinberg & Company P.A. (“Weinberg”) as the Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2025. Weinberg had been previously engaged to audit the financial statements of Dura Medical LLC, which had been acquired by Hope Therapeutics, Inc.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

NRX Pharmaceuticals, Inc. dismissed Salberg & Company P.A. as its auditor.

Action: dismissal
Auditor: Salberg & Company P.A.
Successor: Weinberg & Company P.A.

Exact text from the filing

on or around November 24, 2025 the Audit Committee of the Corporation dismissed Salberg & Company P.A.

View on SEC.gov

Browse all auditor changes →

NRX Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-036452

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.